Asston Pharma to raise ₹27.7 Cr via Preferential Issue

Asston Pharmaceuticals Ltd announced its Board of Directors has approved a preferential issue of up to 24,10,431 equity shares at ₹115 per share, aggregating ₹27.72 crore. The funds will be raised from non-promoter category investors on a cash basis. The company also approved convening an Extraordinary General Meeting (EGM) on July 31, 2026, to seek shareholder approval for this issuance. The Board meeting where these decisions were made commenced at 3:00 PM and concluded at 5:00 PM on July 02, 2026.